Compare Novartis AG (NVS) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Old Dominion Freight Line Inc — how do they compare? Novartis AG trades at $139.7 (market cap $262.28B), while Old Dominion Freight Line Inc trades at $182.12 (market cap $37.71B). The key difference: Novartis AG is far larger — about 7× Old Dominion Freight Line Inc's market cap, and Novartis AG pays the higher dividend (3.45%). Which is the better fit depends on your goals.
| NVS | ODFL | |
|---|---|---|
Market Cap | $262.28B | $37.71B |
Sector | Health | Industrials |
52-Week High | $168.62 | $248.73 |
52-Week Low | $121.80 | $126.29 |
Enterprise Value | $303.60B | $37.45B |
Dividend Yield | 3.45% | 0.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) stock is trading at $137.7, down 13.93% over 24 hours following negative clinical trial news. The technical outlook is bearish with support at $133 and resistance at $138. Fundamentally, the company maintains strong profitability with a 22.5% net income margin and $56.67B revenue in 2025, though recent pipeline setbacks have pressured sentiment. Analyst consensus is mixed with 24% buy ratings but 68% hold, reflecting caution amid growth uncertainties.
The investment outlook is clouded by recent trial failures, but Novartis' solid cash flow and reiterated 5-6% revenue growth guidance through 2030 provide a foundation. Key risks include pipeline execution and competitive threats, while institutional ownership trends will be critical to watch for stability signals. The stock offers value if management can navigate current headwinds effectively.
Old Dominion Freight Line (ODFL) trades at $187.01, up 0.61% on the day, with a bearish technical signal but strong fundamentals. The stock has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue per day rose 12.4% year-over-year in August 2026, though net income margins have softened from 21.99% in 2022 to 18.62% in 2025. The balance sheet remains robust with low debt, and cash flow trends show improved net cash flow in 2026.
Outlook: ODFL's premium valuation (P/E 35.96) demands sustained execution, but analyst consensus targets $238.73 imply ~28% upside. Risks include freight volume pressure and high valuation sensitivity. Institutional buying and cost discipline support momentum, though technical weakness near support at $182 warrants caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
